scorecardresearch
Follow Us:
Wednesday, December 01, 2021

To tackle MDR-TB in time,samples to go to Nagpur

With three more months to set up a laboratory in Aundh for detection of multi-drug resistance tuberculosis city health officials have decided to send the samples to Nagpur.

Written by Anuradha Mascarenhas | Pune |
March 23, 2010 1:17:51 am

Three more months for the testing centre to get started in Aundh

With three more months to set up a laboratory in Aundh for detection of multi-drug resistance tuberculosis (MDR-TB),city health officials have decided to send the samples to Nagpur.

With three per cent of the new tuberculosis patients developing resistance to first line drugs,there is an increasing concern over more cases of MDR-TB,said Dr Dilip Jagtap,chief of the City TB Control Committee. Dr Jagtap added that 82 patients have been suspected with MDR-TB in the city and that for for the first time they plan to send sputum of the 82 suspected patients to the laboratory in Nagpur. He said if the reports test positive,Directly Observed Treatment Short Course (DOTS-PLUS) treatment strategy will be started immediately.

Meanwhile,“On the Move against TB,Innovate to Accelerate Action” forms the theme of the World TB Day (March 24) this year. The city TB control committee has planned awareness programmes to sensitise construction workers,inmates of old age homes,senior citizens and women’s self-help groups. There has also been an increase in the number of private practitioners who have enrolled in the public-private partnership to control TB,Jagtap said.

This year,the city also sees a dip in the number of deaths due to TB-related infections. From January to December,2009,a total of 1,808 new TB patients were detected. A total of 353 TB patients were detected with HIV. However,the city TB control committee chief said there were 192 deaths last year of patients with TB and related complications. This is as against 215 patients who died in 2008.

MDR-TB is triggered when the patient discontinues treatment prematurely and develops resistance to at least isoniazid and rifampicin. DOTS strategy with standardised shortcourse chemotherapy (SCC) using first-line drugs is the mainstay of TB control globally,said Dr Kanchan Jagtap,director of the State TB Training and Demonstration Centre which will set up the MDR-TB lab at the DOTS Plus centre in Aundh.

According to Dr D K Shirole,former president of the state unit of the Indian Medical Association and coordinator of the IMA-Global Fund for AIDS,TB and Malaria programme in Maharashtra,the government has planned to encourage the private sector to set up more DOTS treatment centres and designated microscopy centres.

What is MDR-TB
MDR-TB is triggered when a tuberculosis patient discontinues treatment prematurely and develops resistance to at least two medicines — isoniazid and rifampicin

TbDeaths in city
192deaths in 2009
215deaths in 2008

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Pune News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
Advertisement
Advertisement
Advertisement
Advertisement